Volume 6, Issue 2 (12-2019)                   vacres 2019, 6(2): 14-17 | Back to browse issues page

‎ 10.29252/vacres.6.2.14

XML Print

Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges
Pooneh Rhimi * , Mohammad Reza Aghasadeghi
Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
Abstract:   (4324 Views)
Since the reemergence of a severe acute respiratory syndrome caused by a novel coronavirus (SARS-CoV-2), the disease caused by this virus, known as COVID-19, has been spreading rapidly all around the world. As of early June 2020, COVID-19 has infected more that 6.6 million people, and has caused more than 390,000 deaths, globally. Similar to its pioneers, namely SARS-CoV and MERS-CoV, there is currently no vaccine or specific antiviral treatment against this virus. This review provides a timely overview on efforts as well as different platforms used for developing an effective vaccine against COVID-19.
Keywords: SARS-CoV-2, COVID-19, Spike protein, subunit vaccines, COVID-19 vaccines
Full-Text [PDF 365 kb]   (1656 Downloads)    
Type of Study: Review article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2020/06/8
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.